Low-dose aspirin no aid against cognitive decline

May 9, 2017

(HealthDay)—Low-dose aspirin does not protect against cognitive decline, according to a review published April 20 in the Journal of the American Geriatrics Society.

Nicola Veronese, M.D., from the Italian Research Council in Padova, and colleagues conducted a systematic literature review to identify observational and interventional studies that investigated low-dose aspirin and the incidence of and cognitive impairment.

The researchers identified eight studies (36,196 participants). Over a median of six years of follow-up, chronic use of low-dose aspirin was not associated with onset of dementia or (five studies; 26,159 participants; odds ratio, 0.82; 95 percent confidence interval, 0.55 to 1.22; P = 0.33), after adjusting for a median of three potential confounders. In three randomized controlled trials (10,037 participants; median follow-up, five years), the use of low-dose aspirin in individuals without dementia was not associated with significantly better global cognition (standardized mean difference, 0.005; 95 percent confidence interval, −0.04 to 0.05; P = 0.84).

"This review found no evidence that low-dose aspirin buffers against or dementia or improves cognitive test scores in ," the authors write.

Explore further: Review finds no benefit to aspirin for preserving cognitive function

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Review finds no benefit to aspirin for preserving cognitive function

April 20, 2017
An analysis of published studies found no evidence that low- dose aspirin buffers against cognitive decline or dementia or improves cognitive test scores.

Review links albuminuria to cognitive impairment, dementia

February 13, 2017
(HealthDay)—Albuminuria is associated with cognitive impairment, dementia, and cognitive decline, according to a review published online Feb. 2 in the Journal of the American Geriatrics Society.

ACC: PPI tx also beneficial for those on low-dose aspirin

March 21, 2016
(HealthDay)—For patients requiring dual antiplatelet therapy (DAPT), gastroprotection with proton-pump inhibitors (PPIs) is also beneficial for patients receiving low-dose aspirin, according to a study published online ...

Major bleeding risk from drugs similar in elderly

April 17, 2017
(HealthDay)—The risk of major bleeding is similar for older patients with atrial fibrillation taking either antiplatelet or anticoagulant drugs, according to a review published online April 10 in the Journal of Thrombosis ...

Benefits of cognitive training in dementia patients unclear

February 22, 2017
Positive effects of cognitive training in healthy elderly people have been reported, but data regarding its effects in patients with dementia is unclear.

Is dementia in older women tied to 20-year rate of weight loss?

December 27, 2016
(HealthDay)—For women surviving into late life, the rate of weight loss over 20 years is associated with development of mild cognitive impairment (MCI) or dementia, according to a study published online Dec. 19 in the Journal ...

Recommended for you

Does diabetes damage brain health?

December 14, 2018
(HealthDay)—Diabetes has been tied to a number of complications such as kidney disease, but new research has found that older people with type 2 diabetes can also have more difficulties with thinking and memory.

Amyloid pathology transmission in lab mice and historic medical treatments

December 13, 2018
A UCL-led study has confirmed that some vials of a hormone used in discontinued medical treatments contained seeds of a protein implicated in Alzheimer's disease, and are able to seed amyloid pathology in mice.

Study links slowed brainwaves to early signs of dementia

December 13, 2018
To turn back the clock on Alzheimer's disease, many researchers are seeking ways to effectively diagnose the neurodegenerative disorder earlier.

New discoveries predict ability to forecast dementia from single molecule

December 11, 2018
Scientists who recently identified the molecular start of Alzheimer's disease have used that finding to determine that it should be possible to forecast which type of dementia will develop over time—a form of personalized ...

Researchers classify Alzheimer's patients in six subgroups

December 5, 2018
Researchers studying Alzheimer's disease have created an approach to classify patients with Alzheimer's disease, a finding that may open the door for personalized treatments.

Neuroscientists pinpoint genes tied to dementia

December 3, 2018
A UCLA-led research team has identified genetic processes involved in the neurodegeneration that occurs in dementia—an important step on the path toward developing therapies that could slow or halt the course of the disease. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.